MSKCC Oncologic Toxicity Management Symposium A Multidisciplinary Approach 2024

Name: MSKCC Oncologic Toxicity Management Symposium A Multidisciplinary Approach 2024
Brand: CMEMEDCOM
SKU: 41350
Availability: InStock

$40

Include: 24 videos 20 pdfs, size: 7.26 GB
Target Audience: oncologists

Categories: Critical Care, Emergency Medicine, Hospital Medicine, Internal Medicine, Memorial Sloan Kettering Cancer Center (MSKCC CME), Oncology, Uncategorized Tags: 2024 oncology symposium, advanced oncology interventions, advanced oncology management course MSKCC, adverse event management oncology, adverse event prevention oncology, autoimmune disease cancer therapy, body image cancer, body image cancer survivors, cancer adverse event management course, cancer care best practices, cancer care innovation, cancer care teams, cancer healthcare providers, cancer patient quality of life, cancer patient support, cancer survivorship care, cancer symptom management, cancer therapy dosing consistency, cancer therapy morbidity reduction, cancer therapy updates, cancer toxicity CME, cancer toxicity management conference, cancer treatment side effect management, cancer treatment teams, Cancer Treatment Toxicities, cardiovascular adverse events oncology, CBD cannabis cancer toxicity, CBD cannabis oncology, coping with cancer side effects, coping with cancer treatment side effects, dermatologic adverse events, dermatologic adverse events oncology, dietary recommendations cancer, dietary recommendations cancer toxicity, eczema psoriasis immunotherapy, eczema psoriasis oncology, endocrinologic adverse events, endocrinologic adverse events oncology, evidence-based oncology toxicity, evidence-based toxicity management, exercise oncology, exercise oncology toxicity, fertility preservation oncology, gastrointestinal adverse events, gastrointestinal adverse events oncology, genomic biomarkers oncology, healthcare professionals oncology, immune checkpoint inhibitor toxicity, immunotherapy toxicity course, inflammatory bowel disease immunotherapy, inflammatory bowel disease oncology, Integrative medicine oncology, integrative oncology, management of immunotherapy toxicities, medical professionals oncology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering cancer course, Memorial Sloan Kettering CME, Memorial Sloan Kettering oncology course, MSKCC, MSKCC 2024 symposium, MSKCC cancer course, MSKCC cancer education, MSKCC CME, MSKCC Education, MSKCC multidisciplinary, MSKCC multidisciplinary symposium, MSKCC New York, MSKCC Oncology Course, MSKCC Oncology Education, MSKCC oncology symposium, MSKCC OTM 2024, MSKCC OTM Symposium, MSKCC symposium, MSKCC toxicity management, MSKCC toxicity management course, multidisciplinary cancer care, multidisciplinary cancer specialists, multidisciplinary oncology care, multidisciplinary oncology symposium, neurologic adverse events, neurologic adverse events oncology, New York cancer conference, New York oncology conference, non-pharmacological toxicity interventions, non-pharmacological toxicity management, Nurse practitioner oncology, nurse practitioner oncology education, nurse practitioners oncology, oncologic toxicity CME, oncologic toxicity management, oncologic toxicity management symposium, oncologists, oncology adverse event case studies, oncology adverse event management, oncology adverse event management course, oncology adverse event mechanisms, oncology adverse event prevention, oncology adverse event symposium, oncology case discussions, oncology clinical practice, oncology CME audience, oncology CME course, Oncology continuing education, oncology continuing medical education, oncology education participants oncologic toxicity management symposium, oncology education symposium, oncology education videos, oncology expert faculty, oncology for pharmacists, oncology for physician assistants, oncology for registered nurses, oncology healthcare professionals, oncology interactive sessions, oncology intervention opportunities, oncology learning modules, oncology multidisciplinary approach, oncology nurse education, oncology nurses, oncology panel Q&A, oncology patient care strategies, oncology pdf resources, oncology personalized medicine, oncology pharmacist education, oncology pharmacists, oncology physician assistants, oncology professional development, oncology research translation, oncology specialists, oncology symposium 2024, oncology toxicity prevention oncology professionals, oncology toxicity updates, oncology treatment guidelines, oncology treatment optimization, personalized cancer therapy, personalized cancer toxicity management, personalized oncology toxicity course, physician assistants oncology, psychosocial health oncology, rheumatologic adverse events, rheumatologic adverse events oncology, sexual dysfunction cancer, sexual dysfunction cancer therapy, solid organ transplant immunotherapy, solid organ transplant oncology, targeted therapy adverse events, Zuckerman Research Center symposium Brand: CMEMEDCOM

Description

Include: 24 videos 20 pdfs, size: 7.26 GB

Information:Date & Location

Thursday, June 20, 2024, 8:00 AM – 5:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties

Specialties – Allergy and Immunology, Cardiology, Dermatology, Dermatopathology, Emergency Medicine, Endocrinology, Diabetes and Metabolism, Gastroenterology, Gastrointestinal Oncology, Genitourinary Oncology, Geriatric Medicine, Gynecologic Oncology, Immunotherapy, Integrative Medicine, Medical Oncology, Neurology, Neuro-Oncology, Nurse Practitioner, Rheumatology, Solid Tumor Oncology

Overview

Memorial Sloan Kettering’s 2024 Oncologic Toxicity Management (OTM) Symposium represents a cutting-edge, multidisciplinary approach to managing adverse events associated with modern oncology treatments. The increasing complexity of these treatments, coupled with the influence of genetic, biological, and environmental factors on toxicities, has made effective management a significant challenge. OTM employs advanced tools and techniques to identify individual differences and create personalized treatment plans. By offering evidence-based and tailored treatments for adverse events based on each patient’s unique needs, this program aims to minimize the risk of additional toxicity. This approach contributes to improved quality of life, reduced morbidity, and consistent dosing of cancer therapies.

During this one-day, in-person Symposium, participants will have the opportunity to learn from and interact with experts at the forefront of OTM interventions. The program features a keynote presentation and didactic sessions covering OTM from bench to bedside. Each session will conclude with an interactive panel Q& A with the expert faculty.

The OTM Symposium will cover a diverse range of topics, including:

Updates on Current Adverse Events Specific-Biological Targeted Therapies
The Role of Diet, Exercise, CBD, and Cannabis
Sexual Health, Psychosocial Health, and Fertility
Case Discussions on Challenging Cases of Patients with a Prior History of Autoimmune Disease and Treatment with Immune Checkpoint Inhibitors

The Symposium aims to provide crucial insights into the mechanisms underlying these adverse events, offering opportunities for intervention and personalized patient care.

Who Should Attend

This Symposium is intended for Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses, Pharmacists, and other healthcare professionals treating cancer patients and their associated symptoms.

Objectives

At the conclusion of this Symposium, attendees will be able to:

Evaluate new personalized strategies for preventing and managing treatment related toxicities
Promote the translation of research findings into clinical practice
Discuss non-pharmacological interventions for prevention of toxicities

Topics:

Dietary Recommendation for Management of Oncologic Toxicities.mp4
Dietary Recommendation for Management of Oncologic Toxicities.pdf
Eczema and Psoriasis and Immune Checkpoint Inhibitors.mp4
Eczema and Psoriasis and Immune Checkpoint Inhibitors.pdf
Fertility Preservation.mp4
Fertility Preservation.pdf
Genomic Biomar.mp4
Genomic Biomar.pdf
Inflammatory Bowel Disease and Immune Checkpoint Inhibitors.mp4
Inflammatory Bowel Disease and Immune Checkpoint Inhibitors.pdf
Management of Cardiovascular Adverse Events.mp4
Management of Cardiovascular Adverse Events.pdf
Management of Dermatologic Adverse Events.mp4
Management of Dermatologic Adverse Events.pdf
Management of Endocrinologic Adverse Events.mp4
Management of Endocrinologic Adverse Events.pdf
Management of Gastrointestinal Adverse Events.mp4
Management of Gastrointestinal Adverse Events.pdf
Management of Neurologic Adverse Events.mp4
Management of Neurologic Adverse Events.pdf
Management of Rheumatologic Adverse Events.mp4
Management of Rheumatologic Adverse Events.pdf
OTMsymposium2024_Brochure.pdf
Panel Discussion and Q&A I.mp4
Panel Discussion and Q&A II.mp4
Panel Discussion and Q&A III.mp4
Panel Discussion and Q&A IV.mp4
Panel Discussion and Q&A V.mp4
Psychosocial Health – Body Imaging and Feeling Like Yourself Again.mp4
Psychosocial Health – Body Imaging and Feeling Like Yourself Again.pdf
Psychosocial Health – Coping with the Side Effects of Treatment.mp4
Psychosocial Health – Coping with the Side Effects of Treatment.pdf
Rheumatoid Arthritis and Immune Checkpoint Inhibitors.mp4
Rheumatoid Arthritis and Immune Checkpoint Inhibitors.pdf
Role of CBD Cannabis for Management of Oncologic Toxicities.mp4
Role of CBD Cannabis for Management of Oncologic Toxicities.pdf
Role of Exercise for Management of Oncologic Toxicities.mp4
Role of Exercise for Management of Oncologic Toxicities.pdf
Sexual Dysfunction in Men.mp4
Sexual Dysfunction in Men.pdf
Sexual Dysfunction in Women.mp4
Sexual Dysfunction in Women.pdf
Solid Organ Transplant and Immune Checkpoint Inhibitors.mp4
Solid Organ Transplant and Immune Checkpoint Inhibitors.pdf

MSKCC Oncologic Toxicity Management Symposium A Multidisciplinary Approach 2024

Related products

Login